Pharmacological treatment strategies for neonates with patent ductus arteriosus: a systematic review
Background Patent ductus arteriosus (PDA) has a variety of treatment options, ranging from pharmacologic, with nonsteroidal anti-inflammatory drugs (NSAIDs) as first line therapy, to surgical ligation. However, treatment with NSAIDs is associated with severe side effects as well as many contraindica...
Saved in:
Main Authors: | Oliver Emmanuel Yausep (Author), Adhi Teguh Perma Iskandar (Author) |
---|---|
Format: | Book |
Published: |
Indonesian Pediatric Society Publishing House,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gentamicin in neonates with hemodynamically significant patent ductus arteriosus
by: Kannan Sridharan, et al.
Published: (2023) -
Risk factors for patent ductus arteriosus in preterm neonates
by: Novia Bernati, et al.
Published: (2014) -
Percutaneous closure of patent ductus arteriosus with the Nit-Occlud® patent ductus arteriosus device in 268 consecutive cases
by: Andrii V Maksymenko, et al.
Published: (2019) -
Ibuprofen and paracetamol for patent ductus arteriosus
by: Carlo Dani
Published: (2014) -
Patent Ductus Arteriosus in Preterm Infants
by: Jia-Yuh Chen
Published: (2012)